Published in J Med Chem on August 02, 1996
1,3-Dibenzyl-1H-anthra[1,2-d]imidazole-2,6,11(3H)-trione. Acta Crystallogr Sect E Struct Rep Online (2011) 1.47
1-Dimethyl-amino-9,10-anthraquinone. Acta Crystallogr Sect E Struct Rep Online (2011) 0.99
1,8-Bis(tos-yloxy)-9,10-anthraquinone. Acta Crystallogr Sect E Struct Rep Online (2009) 0.88
Human-mouse genome comparisons to locate regulatory sites. Nat Genet (2000) 8.08
Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Curr Med Chem (2005) 2.57
Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum (1998) 2.28
Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin. J Biol Chem (1991) 1.74
A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol (1995) 1.71
Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res (2000) 1.71
Circulating endothelial progenitor cells in subjects with erectile dysfunction. Int J Impot Res (2005) 1.65
Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab (1998) 1.63
A potential role for the vanilloid receptor TRPV1 in the therapeutic effect of curcumin in dinitrobenzene sulphonic acid-induced colitis in mice. Neurogastroenterol Motil (2007) 1.56
Human cytomegalovirus and restenosis of the internal carotid artery. Stroke (1996) 1.43
Early and rapid diagnosis of CMV infection by nonradioactive in situ hybridization in pediatric kidney transplant recipients. Nephron (1992) 1.39
Phase I-II intraperitoneal mitoxantrone in advanced pretreated ovarian cancer. Eur J Cancer (1993) 1.38
Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II. Mol Pharmacol (1990) 1.32
Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains. Antimicrob Agents Chemother (1986) 1.31
Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression. Cancer Res (1992) 1.29
Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide. Nucleic Acids Res (1991) 1.25
Anthracyclines: selected new developments. Curr Med Chem Anticancer Agents (2001) 1.18
West Nile virus transmission with human cases in Italy, August - September 2009. Euro Surveill (2009) 1.18
Saccharomyces cerevisiae rad51 mutants are defective in DNA damage-associated sister chromatid exchanges but exhibit increased rates of homology-directed translocations. Genetics (2001) 1.17
G1 cell-cycle arrest and apoptosis by histone deacetylase inhibition in MLL-AF9 acute myeloid leukemia cells is p21 dependent and MLL-AF9 independent. Leukemia (2006) 1.13
Mixed sclerosing bone dystrophy. Report of a case and review of the literature. Clin Rheumatol (1996) 1.11
Quinolone binding to DNA is mediated by magnesium ions. Proc Natl Acad Sci U S A (1992) 1.10
Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages. Cell Immunol (2012) 1.09
Growth charts, growth velocity and bone development in childhood obesity. Int J Obes Relat Metab Disord (1995) 1.06
6-Aminoquinolones as new potential anti-HIV agents. J Med Chem (2000) 1.05
Role of multivesicular bodies and their components in the egress of enveloped RNA viruses. Rev Med Virol (2009) 1.04
Separation methods for acyclovir and related antiviral compounds. J Chromatogr B Biomed Sci Appl (2001) 1.04
The effect of the minor groove binding agent DAPI (4,6-diamidino-2-phenyl-indole) on DNA-directed enzymes: an attempt to explain inhibition of plasmid expression in Escherichia coli [corrected]. FEMS Microbiol Lett (1990) 1.03
Genome sequence analysis of the first human West Nile virus isolated in Italy in 2009. Euro Surveill (2009) 1.03
Intranuclear delivery of an antiviral peptide mediated by the B subunit of Escherichia coli heat-labile enterotoxin. Proc Natl Acad Sci U S A (1999) 1.03
DNA topoisomerase II as the primary target of anti-tumor anthracyclines. Anticancer Drug Des (1990) 1.02
Nucleic acid aptamers based on the G-quadruplex structure: therapeutic and diagnostic potential. Curr Med Chem (2009) 1.02
Comparison of doxorubicin-induced DNA damage in doxorubicin-sensitive and -resistant P388 murine leukemia cells. Int J Cancer (1986) 1.01
Giant cell arteritis with an erythrocyte sedimentation rate lower than 50. Clin Rheumatol (2000) 1.00
Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung. Biochim Biophys Acta (1995) 1.00
Drug sensitivity and sequence specificity of human recombinant DNA topoisomerases IIalpha (p170) and IIbeta (p180). Mol Pharmacol (1996) 0.99
Radiosensitive and mitotic recombination phenotypes of the Saccharomyces cerevisiae dun1 mutant defective in DNA damage-inducible gene expression. Genetics (1999) 0.99
Distribution of topoisomerase II cleavage sites in simian virus 40 DNA and the effects of drugs. J Mol Biol (1991) 0.98
Synthesis and biological evaluation of N6-cycloalkyl derivatives of 1-deazaadenine nucleosides: a new class of anti-human immunodeficiency virus agents. J Med Chem (1995) 0.97
On the mechanism of action of quinolone drugs. Trends Microbiol (1993) 0.96
A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line. Cancer Res (2001) 0.96
Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region. Gut (2006) 0.96
A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 0.95
Pyrrolo-quinoline derivatives as potential antineoplastic drugs. Bioorg Med Chem (2000) 0.95
Gene expression of DNA topoisomerases I, II alpha and II beta and response to cisplatin-based chemotherapy in advanced ovarian carcinoma. Int J Cancer (1996) 0.95
Class III alleles of the variable number of tandem repeat insulin polymorphism associated with silencing of thymic insulin predispose to type 1 diabetes. J Clin Endocrinol Metab (2001) 0.94
Ciprofloxacin affects conformational equilibria of DNA gyrase A in the presence of magnesium ions. J Mol Biol (2001) 0.94
The effects of metal ions on the structure and stability of the DNA gyrase B protein. J Mol Biol (2005) 0.94
HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects. J Clin Microbiol (2011) 0.94
Clinical and virological findings in the ongoing outbreak of West Nile virus Livenza strain in northern Italy, July to September 2012. Euro Surveill (2012) 0.94
Quality of life in shift work syndrome. Funct Neurol (1997) 0.94
HSV-2 specific seroprevalence among various populations in Rome, Italy. The Italian Herpes Management Forum. Sex Transm Infect (2000) 0.93
Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells. Cancer Res (1986) 0.93
Recent advances on the role of topological indices in drug discovery research. Curr Med Chem (2001) 0.93
Ovulation induction with clomiphene citrate and metformin in women with polycystic ovary syndrome. Minerva Ginecol (2014) 0.92
Effects of CD4 synthetic peptides on HIV type I envelope glycoprotein function. J Immunol (1992) 0.92
MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: alterations in cellular pharmacokinetics and in pattern of cross-resistance. Int J Cancer (1995) 0.92
Comparison of DNA cleavage induced by etoposide and doxorubicin in two human small-cell lung cancer lines with different sensitivities to topoisomerase II inhibitors. Int J Cancer (1990) 0.92
Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol (2001) 0.92
Genomic sites of topoisomerase II activity determined by comparing DNA breakage enhanced by three distinct poisons. J Mol Biol (1999) 0.92
Do quinolones bind to DNA? Biochem Pharmacol (1988) 0.92
Solid-state infrared absorption spectra and chain arrangement in some synthetic homooligopeptides in the intermolecularly hydrogen-bonded pleated-sheet beta-conformation. Biopolymers (1977) 0.91
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification. J Neuroimmune Pharmacol (2012) 0.91
Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial. Eur Rev Med Pharmacol Sci (2011) 0.91
Herpes simplex virus chronically infected human T lymphocytes are susceptible to HIV-1 superinfection and support HIV-1 pseudotyping. J Acquir Immune Defic Syndr (1999) 0.91
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120. Gene Ther (2005) 0.90
Engineered E. coli delivers therapeutic genes to the colonic mucosa. Gene Ther (2005) 0.90
Rapid diagnosis of influenza type A infection: comparison of shell-vial culture, directigen flu-A and enzyme-linked immunosorbent assay. New Microbiol (1996) 0.90
Novel pyrrolo[3,2-f]quinolines: synthesis and antiproliferative activity. Bioorg Med Chem (2001) 0.90
The topoisomerase II poison clerocidin alkylates non-paired guanines of DNA: implications for irreversible stimulation of DNA cleavage. Nucleic Acids Res (2001) 0.90
Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives. Mol Pharmacol (1995) 0.90
Unexplained infertility and ovulatory induction with menopausal gonadotropins. Minerva Ginecol (2014) 0.90
Sequence specificity of psoralen photobinding to DNA: a quantitative approach. Biochemistry (1992) 0.90
Doxorubicin disaccharide analogue: apoptosis-related improvement of efficacy in vivo. J Natl Cancer Inst (1997) 0.90
Directed evolution to increase camptothecin sensitivity of human DNA topoisomerase I. Chem Biol (2001) 0.90
New developments in antitumor anthracyclines. Pharmacol Ther (1998) 0.89
Irreversible and reversible topoisomerase II DNA cleavage stimulated by clerocidin: sequence specificity and structural drug determinants. Cancer Res (1997) 0.89
Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Gynecol Endocrinol (2005) 0.89
Ovulation induction with clomiphene citrate for infertile couple. Minerva Ginecol (2014) 0.89
A novel approach for the virtual screening and rational design of anticancer compounds. J Med Chem (2000) 0.88
Clustering and risk factors of methicillin-resistant Staphylococcus aureus carriage in two Italian long-term care facilities. Infection (2008) 0.88
Relationship between lethal effects and topoisomerase II-mediated double-stranded DNA breaks produced by anthracyclines with different sequence specificity. Mol Pharmacol (1997) 0.88
Measles in Italy, July 2009 to September 2010. Euro Surveill (2011) 0.88
Conformational drug determinants of the sequence specificity of drug-stimulated topoisomerase II DNA cleavage. J Mol Biol (1994) 0.88
Dinuclear Zn(2+) complexes of synthetic heptapeptides as artificial nucleases. J Am Chem Soc (2001) 0.88
Topoisomerase I gene expression and cell sensitivity to camptothecin in human cell lines of different tumor types. Anticancer Drugs (1994) 0.87
On the oxy analogues to the 4 leads to 1 intramolecularly hydrogen-bonded peptide conformations. Macromolecules (1976) 0.87
Pt-based drugs: the spotlight will be on proteins. Metallomics (2014) 0.87
The catalytic subunit of herpes simplex virus type 1 DNA polymerase contains a nuclear localization signal in the UL42-binding region. Virology (2000) 0.87
Inhibitors of HIV-1 Tat-mediated transactivation. Curr Med Chem (2006) 0.87
Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1 and nalidixic acid. Biochem Pharmacol (1988) 0.87
Red wine micronutrients as protective agents in Alzheimer-like induced insult. Life Sci (2003) 0.87